Showing results (61-70 of 100) with videos related to
Sort By:
Pageof 10
Cell Reports|September 15, 2021
AIM/CD5L attenuates DAMPs in the injured brain and thereby ameliorates ischemic strokeNatsumi Maehara, Kaori Taniguchi, Ami Okuno, et al.Journal of Atherosclerosis and Thrombosis|September 3, 2025
Association between Serum Interleukin-6 Levels and Long-term Outcomes after Ischemic Stroke: A Prospective Cohort StudySatoko Arai, Takao Hoshino, Takafumi Mizuno, et al.Respiratory Research|August 17, 2023
Apoptosis inhibitor of macrophage (AIM)/CD5L is involved in the pathogenesis of COPDMichiko Takimoto-Sato, Masaru Suzuki, Hiroki Kimura, et al.Nature Communications|May 16, 2013
PAD4 regulates proliferation of multipotent haematopoietic cells by controlling c-myc expressionKatsuhiko Nakashima, Satoko Arai, Akari Suzuki, et al.Surgery Today|August 1, 2024
Treatment outcomes in non-occlusive mesenteric ischemia and post-treatment return to social activitiesGaku Ohira, Koichi Hayano, Toru Tochigi, et al.Journal of Atherosclerosis and Thrombosis|December 1, 2024
Effect of Pemafibrate on Cerebrovascular Atherosclerosis in Patients with Stroke and HypertriglyceridemiaTakao Hoshino, Kentaro Ishizuka, Misa Seki, et al.Atherosclerosis|May 8, 2025
Residual lipoprotein(a)-associated risk in patients with stroke or transient ischemic attackTakao Hoshino, Takafumi Mizuno, Satoko Arai, et al.Journal of the American Society of Nephrology : JASN|July 3, 2020
Crucial Role of AIM/CD5L in the Development of Glomerular Inflammation in IgA NephropathyAkiko Takahata, Satoko Arai, Emiri Hiramoto, et al.Journal of Autoimmunity|November 25, 2023
AIM/CD5L ameliorates autoimmune arthritis by promoting removal of inflammatory DAMPs at the lesionsKeisuke Yasuda, Shieri Shimodan, Natsumi Maehara, et al.Cell Reports|May 29, 2026
CD5L promotes phagocytic removal of amyloid β oligomers and improves cognitive function in a mouse model of Alzheimer's diseaseNatsumi Maehara, Satoko Hattori, Akira Nakamura, et al.Pageof 10